| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Frederick T Muto last filed a Form 4 in July 2022, as Director at IONS. Frederick T Muto's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 59,597 shares of IONS. The IONS filings lean toward selling, a net 38,000 shares.
Frederick T Muto has 10 Form 4 filings on record from May 2019 to July 2022, all as Director at Ionis Pharmaceuticals (IONS), 2019–2022.
The 34 reported transactions were 21 option exercises, 8 option or other derivative awards and 5 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $2.1M.
The largest open-market sale was 15,000 shares of IONS at an average $65.29 on June 4, 2019, about $979K.
Shares as reported in the last Form 4 for each company; the most recent is from July 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2021 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 15,000 | $36.63 | $549,500.00 | -32.1% | -1.1% | -5.5% | |
| Jun 4, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 15,000 | $65.29 | $979,350.00 | -60.5% | - | - | |
| May 6, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 8,000 | $72.75 | $582,001.60 | -45.0% | - | - |